Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|New England Journal of Medicine|2016Cited by 595
A large peptidome dataset improves HLA class I epitope prediction across most of the human populationSiranush Sarkizova, Derin B. Keskin, Jennifer M. Rosenbluth et al.|Nature Biotechnology|2019Cited by 539
A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantationMatthew S. Davids, Philippe Armand, Haesook T. Kim et al.|Blood|2020Cited by 98
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependenciesElisa ten Hacken, Catherine J. Wu, Rebecca Valentin et al.|JCI Insight|2018Cited by 52
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantationLivius Penter, Catherine J. Wu, Yi Zhang et al.|Blood|2021Cited by 42